Dysbiosis of fecal microbiota and high frequency of Citrobacter, Klebsiella spp., and Actinomycetes in patients with irritable bowel syndrome and gastroenteritis
Gastroenterology and Hepatology from Bed to Bench,
Vol. 9 No. 4 (2016),
9 October 2016
,
Page 325-330
https://doi.org/10.22037/ghfbb.v0i0.839
Abstract
.- Key word
- Irritable bowel syndrome
- gut microbiota
- culture based method
How to Cite
References
Reference List
(1) Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature 2009;457(7228):480-4.
(2) Tap J, Mondot S, Levenez F, Pelletier E, Caron C, Furet J, et al. Towards the human intestinal microbiota phylogenetic core. Environmental microbiology 2009;11(10):2574-84.
(3) Balsari A, Ceccarelli A, Dubini F, Fesce E, Poli G. The fecal microbial population in the irritable bowel syndrome. Microbiologica 1982;5(3):185-94.
(4) Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003;52(2):237-42.
(5) Si JM, Yu YC, Fan YJ, Chen SJ. Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol 2004;10(12):1802-5.
(6) M++ller-Lissner SA, Bollani S, Brummer RJ, Coremans G, Dapoigny M, Marshall JK, et al. Epidemiological aspects of irritable bowel syndrome in Europe and North America. Digestion 2001;64(3):200-4.
(7) Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130(5):1480-91.
(8) Spiller RC. Role of infection in irritable bowel syndrome. Journal of gastroenterology 2007;42(17):41-7.
(9) Chadwick VS, Chen W, Shu D, Paulus B, Bethwaite P, Tie A, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002;122(7):1778-83.
(10) Simren M, Abrahamsson H, Bj+¦rnsson ES. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome. Gut 2001;48(1):20-7.
(11) Othman M, Ag++ero R, Lin HC. Alterations in intestinal microbial flora and human disease. Current opinion in gastroenterology 2008;24(1):11-6.
(12) +ûhman L, Simr+¬n M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nature Reviews Gastroenterology and Hepatology 2010;7(3):163-73.
(13) Pimentel M, Lezcano S. Irritable bowel syndrome: bacterial overgrowthGÇöwhatGÇÖs known and what to do. Current treatment options in gastroenterology 2007;10(4):328-37.
(14) Ringel Y, Carroll IM. Alterations in the intestinal microbiota and functional bowel symptoms. Gastrointestinal endoscopy clinics of North America 2009;19(1):141-50.
(15) Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, Fukudo S. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterology & Motility 2010;22(5):512-e115.
(16) Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. Enterotypes of the human gut microbiome. Nature 2011;473(7346):174-80.
(17) Carroll IM, RingelGÇÉKulka T, Siddle JP, Ringel Y. Alterations in composition and diversity of the intestinal microbiota in patients with diarrheaGÇÉpredominant irritable bowel syndrome. Neurogastroenterology & Motility 2012;24(6):521-e248.
(18) Si JM, Yu YC, Fan YJ, Chen SJ. Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol 2004;10(12):1802-5.
(19) M+ñtt+¦ J, Maunuksela L, Kajander K, Palva A, Korpela R, Kassinen A, et al. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndromeGÇôa longitudinal study in IBS and control subjects. FEMS Immunology & Medical Microbiology 2005;43(2):213-22.
(20) Rajili-çGÇôStojanovi-ç M, Biagi E, Heilig HG, Kajander K, Kekkonen RA, Tims S, et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 2011;141(5):1792-801.
(21) Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003;52(2):237-42.
(22) Jeffery IB, O'Toole PW, +ûhman L, Claesson MJ, Deane J, Quigley EM, et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 2012;61(7):997-1006.
(23) Zoetendal EG, Rajili-ç-Stojanovi-ç M, De Vos WM. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 2008;57(11):1605-15.
- Abstract Viewed: 287 times
- PDF Downloaded: 245 times
- PDF Downloaded: 104 times